Directory

>

Richard Pulik

avatar

Richard Pulik

Chief Financial Officer | Roivant Sciences

New York, New York, United States

View contact details (it's free)

Richard Pulik

Summary

Richard Pulik is the Chief Financial Officer at Roivant Sciences, where he leverages over two decades of experience in finance and corporate strategy within the healthcare sector. Before joining Roivant in September 2021, Richard held significant roles at Novartis, including Global Head of Business Development & Licensing for Oncology. His career includes pivotal positions in investment banking at Bank of America Merrill Lynch and UBS, focusing on mergers and acquisitions. Richard holds a B.S. in Finance from The Wharton School and a B.A. in Economics and International Relations from the University of Pennsylvania. He is multilingual, with proficiency in German, which complements his international experience. Richard's diverse background in both corporate and investment environments equips him with a unique perspective on financial strategy. He is passionate about enhancing healthcare delivery globally and has a deep-rooted interest in developing transformative medicines.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Richard Pulik

Work Experience

company logo

Chief Financial Officer at

Roivant Sciences

September 2021 - Present

company logo

Global Head of BD&L and Portfolio Management, Oncology at

Novartis

August 2019 - August 2021

company logo

US Head Investor Relations, Vice President at

Novartis

January 2015 - July 2019

company logo

Senior Director Mergers & Acquisitions at

Novartis

January 2012 - January 2015

company logo

Vice President, Investment Banking, Mergers & Acquisitions at

Merrill Lynch

January 2006 - January 2012

💼

Associate at

Monitor

January 2004 - January 2006

company logo

Associate at

UBS Group AG

June 2000 - August 2004

company logo

Intern at

Siemens AG

June 1999 - August 1999

Logos provided by Logo.dev

Richard Pulik

Education

Wharton School, B.S.

January 1997 - January 2001

University of Pennsylvania, Ba

January 1997 - January 2001

Phillips Exeter Academy

January 1993 - January 1997

Frequently Asked Questions about Richard Pulik

What is Richard Pulik email address?

Richard Pulik's primary email address is *************@roivant.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Richard Pulik work for?

Richard Pulik is a Chief Financial Officer at Roivant Sciences.

Where Richard Pulik graduated from?

Richard Pulik holds a degree in Finance from Wharton School.

How can I directly contact Richard Pulik?

To contact Richard Pulik directly, you can use the email address *************@roivant.com. Complete contact information is available upon registration with Muraena.

Is Richard Pulik an immigrant?

Yes, Richard Pulik is an immigrant and currently based in United States

Who is Richard Pulik?

Richard Pulik is the Chief Financial Officer at Roivant Sciences, where he leverages over two decades of experience in finance and corporate strategy within the healthcare sector. Before joining Roivant in September 2021, Richard held significant roles at Novartis, including Global Head of Business Development & Licensing for Oncology. His career includes pivotal positions in investment banking at Bank of America Merrill Lynch and UBS, focusing on mergers and acquisitions. Richard holds a B.S. in Finance from The Wharton School and a B.A. in Economics and International Relations from the University of Pennsylvania. He is multilingual, with proficiency in German, which complements his international experience. Richard's diverse background in both corporate and investment environments equips him with a unique perspective on financial strategy. He is passionate about enhancing healthcare delivery globally and has a deep-rooted interest in developing transformative medicines.

Richard`s contact details

mail

*************@roivant.com

Colleagues

avatar
Srini Ramanathan

Chief Development Officer

avatar
Paul Davis

Chief Communications Officer

avatar
Sudhir Penugonda

Executive Director

avatar
Stephanie Lee Griffin

VP, Special Projects, Office of CEO

avatar
Drew Fromkin

Chief Executive Officer

avatar
Shingai Majuru

Vice President, Head of CMC, Small Molecule Development

Eric Valeur

VP, Research

Keith Haan

Senior Vice President, Investments

avatar
Daniel Patterson

Vice President, Head of CMC, Biologics and Gene Therapies

View Contact details (it's free)
Request Profile Removal